Mel is an accomplished healthcare executive with 20 years’ experience spanning clinical research, marketing, strategic consulting and value, and evidence generation with successful global product launches. He is primarily focused at the forefront of functional developments in integrated care solutions, market access, pricing, evidence generation, and policy.
Most recently, Mel was VP and Head of Global Market Access at Takeda, responsible for directing and creating a global market access, health economics, payer solutions, and evidence demonstration and pricing function responsible for developing, coordinating, and driving all market access and payer value generation strategies for the organization. He championed new business and customer engagement models and value-added collaborative partnerships. Prior to joining Takeda, Mel held varying market access and corporate affairs related roles of increasing responsibility at Amgen in both the U.S. and Europe. Prior to his market access experience, Mel worked as a management consultant as well as holding diverse industry roles in marketing and commercial development. Before joining the biopharmaceutical industry, Mel held academic and research appointments at the College of Physicians and Surgeons of Columbia University, New York, and St. Luke’s-Roosevelt Hospital Centre and Helen Hayes Hospital, New York.
Mel completed his PhD (medicine) at the University of Melbourne, Australia. He then completed his post-doctoral training in the department of medicine at Columbia University, New York. Mel also holds an Executive MBA from the Lubin School of Business, New York. His research interests include osteoporosis and metabolic bone diseases, health economics and technology assessments, and health policy analysis.